Durroux T, Peter M, Turcatti G, Chollet A, Balestre M N, Barberis C, Seyer R
INSERM U 469 and CNRS UPR 9023, CCIPE, 141, rue de la Cardonille, 34094 Montpellier Cedex 5, France.
J Med Chem. 1999 Apr 8;42(7):1312-9. doi: 10.1021/jm9804782.
Fluoresceinyl and rhodamyl groups have been coupled by an amide link to side-chain amino groups at positions 1, 6, and 8 of pseudo-peptide linear vasopressin antagonists (Manning et al. Int. J. Pept. Protein Res. 1992, 40, 261-267) through different positions on the fluorophore, to give tetraethylrhodamyl-DTyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 (2), 4-HOPh(CH2)2CO-DTyr(Me)-Phe-Gln-Asn-Lys(5-carboxyfl uoresceinyl)-Pro-A rg-NH2 (4), 4-HOPh(CH2)2CO-DTyr(Me)-Phe-Gln-Asn-Lys(5- or 6-carboxytetramethylrhodamyl)-Pro-Arg-NH2 (5, 6), 4-HOPh(CH2)2CO-DTyr(Me)-Phe-Gln-Asn-Arg-Pro-Lys(5- or 6- carboxyfluoresceinyl)-NH2 (8, 9), and 4-HOPh(CH2)2CO-DTyr(Me)-Phe-Gln-Asn-Arg-Pro-Lys(5- or 6- carboxytetramethylrhodamyl)-NH2 (10, 11). The closer to the C-terminus the fluorophore, the higher the affinities of the fluorescent derivatives for the human vasopressin V1a receptor transfected in CHO cells. The compound 10 has a Ki of 70 pM, as determined by competition experiments with [125I]-4-HOPhCH2CO-DTyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-NH2. It showed a good selectivity for human V1a receptor versus human OT (Ki = 1.2 nM), human vasopressin V1b (Ki approximately 27 nM), and human vasopressin V2 (Ki > 5000 nM) receptor subtypes. All fluorescent analogues were antagonists as shown by the inhibition of vasopressin induced inositol phosphate accumulation. These fluorescent ligands are efficient for labeling cells expressing the human V1a receptor subtype, as shown by flow cytofluorometric experiments or fluorescence microscopy. They are also appropriate tools for structural analysis of the vasopressin receptors by fluorescence.
荧光素基和罗丹明基已通过酰胺键与拟肽线性血管加压素拮抗剂(Manning等人,《国际肽与蛋白质研究杂志》,1992年,40卷,261 - 267页)第1、6和8位侧链氨基通过荧光团上的不同位置偶联,得到四乙基罗丹明 - DTyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2(2)、4-HOPh(CH2)2CO-DTyr(Me)-Phe-Gln-Asn-Lys(5-羧基荧光素基)-Pro-A rg-NH2(4)、4-HOPh(CH2)2CO-DTyr(Me)-Phe-Gln-Asn-Lys(5-或6-羧基四甲基罗丹明基)-Pro-Arg-NH2(5、6)、4-HOPh(CH2)2CO-DTyr(Me)-Phe-Gln-Asn-Arg-Pro-Lys(5-或6-羧基荧光素基)-NH2(8、9)以及4-HOPh(CH2)2CO-DTyr(Me)-Phe-Gln-Asn-Arg-Pro-Lys(5-或6-羧基四甲基罗丹明基)-NH2(10、11)。荧光团越靠近C末端,荧光衍生物对转染到CHO细胞中的人血管加压素V1a受体的亲和力越高。通过与[125I]-4-HOPhCH2CO-DTyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-NH2的竞争实验测定,化合物10的Ki为70 pM。它对人V1a受体相对于人催产素(Ki = 1.2 nM)、人血管加压素V1b(Ki约为27 nM)和人血管加压素V2(Ki > 5000 nM)受体亚型表现出良好的选择性。如血管加压素诱导的肌醇磷酸积累的抑制所示,所有荧光类似物均为拮抗剂。如流式细胞荧光分析实验或荧光显微镜所示,这些荧光配体对于标记表达人V1a受体亚型的细胞是有效的。它们也是通过荧光对血管加压素受体进行结构分析的合适工具。